{"news_desk": "National", "print_page": "1", "section_name": "Health", "subsection_name": null, "byline": {"original": "By GINA KOLATA", "person": [{"rank": 1, "role": "reported", "firstname": "Gina", "organization": "", "lastname": "KOLATA"}]}, "abstract": "Expert panel recommends Food and Drug Admin approve strong new drug to protect against heart attacks; it would be first in new group of medicines that substantially lower levels of cholesterol, leading cause of heart disease; drugs are made by Sanofi, Regeneron Pharmaceuticals and Amgen.", "type_of_material": "News", "word_count": "1306", "lead_paragraph": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease, the biggest killer of Americans.", "pub_date": "2015-06-10T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Federal Panel Backs Approval of New Drug to Fight Heart Attacks", "print_headline": "Drug to Fight Heart Attack Clears Panel "}, "snippet": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease, the biggest killer of Americans.", "multimedia": [{"height": 126, "url": "images/2015/06/10/us/DRUGS/DRUGS-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/06/10/us/DRUGS/DRUGS-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/06/10/us/DRUGS/DRUGS-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/06/10/us/DRUGS/DRUGS-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/06/10/us/DRUGS/DRUGS-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/06/10/us/DRUGS/DRUGS-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/10/health/cholesterol-levels-ldl-drugs-heart-attacks-fda-panel.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Cholesterol", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Amgen Inc", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Sanofi SA", "name": "organizations"}, {"rank": "6", "is_major": "Y", "value": "Regeneron Pharmaceuticals Inc", "name": "organizations"}, {"rank": "7", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject"}], "blog": [], "_id": "5577161138f0d82f50f5750d", "source": "The New York Times"}